American Diabetes Association “Standards of Medical Care in Diabetes” is based on a complete review of the relevant literature by a diverse group of highly trained clinicians and researchers. After weighing the quality of evidence, from rigorous double-blind clinical trials to expert opinion, recommendations are drafted, reviewed, and submitted for approval to the American Diabetes Association Executive Committee. To see the 2021 Standards, please visit

The American Diabetes Association’s Scientific Sessions Planning Committee is soliciting noteworthy session proposals for the 81st Scientific Sessions, which will be held 25–29 June 2021 at the Walter E. Washington Convention center in Washington, D.C. The committee encourages submissions that are innovative, challenge current treatment paradigms, and represent the latest advances in basic, clinical, and translational science. The submission deadline is 11 January 2021. Please visit for further information.

“Diabetes and COVID-19” is an online collection of articles on the Diabetes Care website featuring the latest studies, clinical observations, and commentaries on COVID-19 with specific relation to patients with diabetes. Topics include management of diabetes and its complications during the pandemic, blood glucose control and remote glucose monitoring, and outcomes in patients with hyperglycemia, cardiovascular risk, and obesity. This web page is updated regularly as relevant Diabetes Care articles are published online ahead of print. To access the collection, visit

This special three-episode series (made possible by an independent educational grant from Sanofi) explores the multiple facets of therapeutic inertia. Drs. Neil Skolnik and John Russell present and discuss the latest clinically relevant articles and information related to the impact of therapeutic inertia, the importance of getting to goal, and the benefits of simultaneous intensification versus sequential treat-to-fail approaches for patients with diabetes. To listen to the complete series, visit

International consensus statement “Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range" is now available in six languages: English, French, Italian, Spanish, German, and Japanese. This consensus statement provides evidence-based guidelines for continuous glucose monitoring (CGM), as determined by an international panel of diabetes experts striving for consistent parameters for CGM blood glucose goals in both research and clinical settings. Access the study in all languages at

In a series of short videos now available on the Clinical Diabetes website, an expert panel moderated by John Anderson, MD, discusses approaches to optimizing basal insulin initiation and treatment in people with type 2 diabetes, including those at high risk such as individuals with renal impairment and older adults, with a focus on reaching A1C goals while mitigating the risk for hypoglycemia. An executive summary and videos of the full panel can be found at

The American Diabetes Association is dedicated to ensuring that you stay informed of the latest COVID-19 research and guidelines. Our new online page for diabetes professionals includes essential resources and information—including webinars, patient guidance, relevant news articles, a discussion forum, and more. Follow updates and join the conversation at

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at